Cipla rolls out mobile application for asthma screening

NEW DELHI: Drug firm Cipla on Monday said it has launched a mobile application designed to enable the first line of screening for asthma in India.

According to the Global Burden of Disease report, the total burden of asthma in India is estimated to be around 34.3 million.

India has a three-fold higher mortality rate and two-fold higher asthma-associated disability burden compared to the global proportion.

Source: PTI News

Digitalmitra